期刊文献+

绝经后女性非酒精性脂肪肝患者miR-122-5p及FOXO3水平与骨质疏松的相关性研究

Correlation between serum miR-122-5p and FOXO3 levels and osteoporosis in postmenopausal women with non-alcoholic fatty liver disease
原文传递
导出
摘要 目的探讨绝经后女性非酒精性脂肪肝(non-alcoholic fatty liver disease,NAFLD)患者miR-122-5p及FOXO3为叉头框蛋白O3(forkhead box protein O3,FOXO3)水平与骨质疏松(osteoporosis,OP)的相关性研究。方法收集30例绝经后女性NAFLD患者与48例绝经后女性非NAFLD患者的临床资料及血清。qRT-PCR检测血清中miR-122-5p、FOXO3水平。生化自动分析仪检测甘油三酯、高密度脂蛋白、低密度脂蛋白。骨密度分析仪检测第1~4腰椎、Wards三角骨、股骨颈、大转子、全髋5个部位的骨密度。分析以上临床指标与骨质疏松的相关性。结果miR-122-5p在绝经后女性NAFLD患者中表达为0.76±0.28,较非NAFLD患者的1.00±0.31表达低(t=3.43,P=0.001)。借助生物信息学网站分析得出miR-122-5p的下游靶基因FOXO3。FOXO3在绝经后女性NAFLD患者中表达为1.31±0.30,较非NAFLD患者的1.00±0.27表达升高(t=4.73,P<0.001)。Student’s t检验与Logistic回归分析显示甘油三酯、miR-122-5p、FOXO3水平是NAFLD患病的危险因素(均P<0.05)。Pearson相关系数显示miR-122-5p水平与股骨颈(r=0.49,P=0.006)、大转子(r=0.37,P=0.046)、全髋(r=0.40,P=0.027)的骨密度呈显著正相关,FOXO3水平与股骨颈(r=-0.45,P=0.014)、全髋(r=-0.51,P=0.004)骨密度呈显著负相关,其余指标相关性不明显(均P>0.05)。结论绝经后女性NAFLD患者血清miR-122-5p水平降低、FOXO3水平升高可能增加患者患骨质疏松的风险。 Objective To investigate the correlation between serum miR-122-5p and FOXO3 levels and osteoporosis(OP)in postmenopausal women with non-alcoholic fatty liver disease(NAFLD).Methods The clinical data and serum of 30 postmenopausal women with NAFLD and 48 postmenopausal women with no-NAFLD were collected.The levels of miR-122-5p and FOXO3 in serum were detected by qRT-PCR.Triglycerides,high-density lipoproteins,and low-density lipoproteins were detected by biochemical autoanalyzer.The bone mineral density of lumbar vertebrae 1-4,Wards triangular bone,femoral neck,greater trochanter and total hip was detected by bone mineral density analyzer.The correlation between the above clinical indicators and OP was analyzed.Results The expression of miR-122-5p in postmenopausal female NAFLD patients(0.76±0.28)was lower than that in non-NAFLD patients(1±0.31)(t=3.43,P=0.001).The downstream target gene FOXO3 of miR-122-5p was identified by bioinformatics website analysis.The expression of FOXO3 in postmenopausal female NAFLD patients(1.31±0.30)was higher than that in non-NAFLD patients(1±0.27)(t=4.73,P<0.001).Student’s t test and Logistic regression analysis showed that triglyceride,miR-122-5p and FOXO3 levels were risk factors for NAFLD(all P<0.05).Pearson correlation coefficient showed that miR-122-5p level was significantly positively correlated with BMD of femoral neck(r=0.488,P=0.006),greater trochanter(r=0.367,P=0.046)and whole hip(r=0.404,P=0.027).FOXO3 level was negatively correlated with bone mineral density of femoral neck(r=-0.445,P=0.014)and whole hip(r=-0.507,P=0.004),while other indexes were not significantly correlated(all P>0.05).Conclusion Decreased serum miR-122-5p level and increased FOXO3 level in postmenopausal women with NAFLD may increase the risk of OP.
作者 张方洁 王松 张国民 赵瑞娟 刘耀敏 Zhang Fangjie;Wang Song;Zhang Guomin;Zhao Ruijuan;Liu Yaomin(Department of Infectious Diseases,Affiliated Hospital of Chengde Medical University,Chengde 067000,China;Department of Thyroid Surgery,Affiliated Hospital of Chengde Medical University,Chengde 067000,China)
出处 《中华内分泌外科杂志》 CAS 2023年第6期748-752,共5页 Chinese Journal of Endocrine Surgery
基金 承德市科学技术研究与发展计划项目(202006A039)。
关键词 绝经后女性 非酒精性脂肪肝 miR-122-5p 叉头框蛋白O3 骨质疏松 骨密度 Postmenopausal women Non-alcoholic fatty liver disease miR-122-5p Forkhead box protein O3 Osteoporosis Bone mineral density
  • 相关文献

参考文献2

二级参考文献22

  • 1Li M,Xu Y,Xu M, et al. Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle- aged and elderly chinese[ J]. J Clin Endocrinol Metab,2012, 97 (6) :2033 - 2038.
  • 2Farnbacher M J, Schoen C, Rabenstein T, et al. Pancreatic duct stones in chronic pancreatitis: criteria for treatment intensity and success[ J]. Gastrointest Endosc ,2002,56 (4) :501 - 506.
  • 3Samelson E J, Cupples LA,Hannan MT, et al. Long-term effects of serum cholesterol on bone mineral density in women and men : the Framingham osteoporosis study [ J ]. Bone, 2004, 34 (3) :557 -561.
  • 4Raisz LG. Pathogenesis of osteoporosis : concepts, conflicts, and prospects[ J]. J Clin Invest,2005,115 (12) :3318 - 3325.
  • 5Seeman E. Estrogen, androgen and the pathogenesis of bone fragility in women and men [ J ]. Curr Osteoporos Rep,2004,2 (3) :90 -96.
  • 6Tatsuno I,Terano T,Nakamura M,et al. Lifestyle and osteopo- rosis in middle-aged and elderly women: Chiba bone survey [ J ]. Endocrine J, 2013,60 ( 5 ) :643 - 650.
  • 7Khosla S, Melton L, Riggs BL. The unitary model for cstrogn deficiency and the pathogenesis of osteoporosis: is a revision needed[J]. J Bone Miner Res,2011,26(3) :441 -451.
  • 8Rachon D, Mysliwska J, Suchecka-Rachon K, et al. Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausal women [ J ]. J Endo- crinol,2002,172(2) :387 - 395.
  • 9Raebon D. Role of tumor necrosis factor (TNF) and interleukin- 6 (IL6) in the pathogenesis of late complications of menopause. Effects of hormone replacement therapy on TNF and IL-6 ex- pression[ J ]. Pol Merkur Lekarski ,2005,18 ( 108 ) :724 - 727.
  • 10Luegmayr E, Glantschnig H, Wesolowski GA, et al. Osteoelast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins [ J]. Cell Death Differ, 2004,11(1): 108-118.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部